Next Quarterly Earnings
Tuesday, August 18, 2026
CW 34
Pre-Market
In 44 days
Legend Biotech ADR
Legend Biotech ADR is a leading biopharmaceutical company dedicated to developing innovative cell therapies. Specializing in groundbreaking CAR-T cell therapies, it targets cancer treatment. Through cutting-edge biotechnology, Legend Biotech ADR strives to create patient-centric solutions and revolutionize cancer therapy.
All Dates
Earnings history data not available
Company Information
Name
Legend Biotech ADR
Country
🇺🇸
More Financial Information